Using near-infrared light during sleep to improve blood flow and slow Alzheimer's disease progression

Sleep-dependent mechanisms of improving cerebral blood flow and reducing Alzheimer's disease progression by photobiomodulation with near-infrared light

NIH-funded research Boston VA Research Institute, INC. · NIH-11017854

This study is looking at how using near-infrared light therapy while you sleep could help improve blood flow in the brain and slow down Alzheimer's disease, with the goal of finding a new way to support brain health for people living with this condition.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston VA Research Institute, INC. NIH-funded
Lab location1 site (Boston, United States)
Project IDNIH-11017854 on NIH RePORTER

What this research studies

This research investigates how near-infrared light therapy can enhance cerebral blood flow and potentially slow the progression of Alzheimer's disease. The approach focuses on delivering this light during non-rapid eye movement sleep, which may optimize its effects on brain health. The study aims to understand the mechanisms by which this light therapy works, including its impact on nitric oxide production and the clearance of amyloid plaques associated with Alzheimer's. By exploring these mechanisms, the research hopes to establish a new treatment strategy for patients with Alzheimer's disease.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease who are experiencing cognitive decline.

Not a fit: Patients with other forms of dementia or those who do not have Alzheimer's disease may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to a novel non-invasive treatment that slows the progression of Alzheimer's disease and improves cognitive function.

How similar studies have performed: While the use of near-infrared light for brain treatment is a relatively novel approach, preliminary studies have shown promise in related areas, suggesting potential for success.

Where this research is happening

Boston, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.